Vitro Diagnostics Inc. (fka VODG)

[Potse]

RickKayne...HemoGenix.....

What is your interpretation of this?
Raise capital and reverse merge into VODG seems like the direction.?

I don't see it as being anything specifically related to any possible RM with VODG. I just find it a bit interesting because it seems to be somewhat out of the ordinary from the time I have followed/monitored the company.

Early last year HemoGenix introduced a bunch of new assay platforms (some of which include VODG's cell culture media), hired at least 5 sales/marketing people just prior to the introduction of those new products, and HemoGenix CEO Ivan Rich increased his presence on the conference circuit in 2012 with some high-profile presentations and speaking opportunities. So with HemoGenix seemingly more interested in attracting outside investment it might be an indication that HemoGenix sees a need for more growth/expansion capital.

Neuromics and HemoGenix are probably the most likely/obvious candidates for some type of merger with VODG because James Musick has more or less hinted at that possibility in his press releases and filings during the time VODG has been associated with those companies.

But there are no shortage of potential RM or acquisition candidates out there (many right there in the Denver/Colorado area) if Musick decides he wants to make some type of strategic move either in the biotech/medical sector, or take the operating company private and enter into a RM with a company outside of that particular sector if a better/irresistible opportunity arose.

Due to difficult market conditions traditional IPOs are pretty much out of the question for anything except the largest, most high-profile private companies now and for the foreseeable future. And although the federal government (and SEC) continues to try and strangle the life out of smaller companies and reverse merger opportunities, the fact remains that the RM route is about the only realistic exit opportunity remaining for owners/investors to try to maximize their holdings/investments.

I noticed back in June 2012, Clifford Neuman (VODG's lawyer and the President of GBCS) decided to begin the process of divesting the casino operations out of GBCS. Christopher Brogdon (Chief Acquisition Officer and Vice Chairman of AdCare Healthcare Systems -- NYSE: ADK) is using the GBCS shell for his new healthcare REIT company. It is a bit surprising that someone like Brogdon decided not to use an already clean, ready-to-go shell, but it just goes to show you that just about anything can happen in the RM world if you know or have connections to the right people.